Daniel Hoffmann Selected Research

TCVS

1/2019

A network of trans-cortical capillaries as mainstay for blood circulation in long bones.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniel Hoffmann Research Topics

Disease

14	Infections 01/2022 - 06/2010
10	Neoplasms (Cancer) 11/2022 - 01/2013
3	Virus Diseases (Viral Diseases) 10/2023 - 01/2015
3	COVID-19 01/2021 - 01/2020
2	Parkinson Disease (Parkinson's Disease) 04/2024 - 10/2013
2	Merkel Cell Carcinoma 01/2022 - 01/2020
2	Hypertrophy 01/2020 - 01/2019
2	Wounds and Injuries (Trauma) 03/2019 - 06/2009
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024
1	Noncommunicable Diseases 09/2022
1	Coinfection 09/2022
1	Carcinogenesis 01/2022
1	Abscess 11/2021
1	Melanoma (Melanoma, Malignant) 06/2021
1	Testicular Neoplasms (Testicular Cancer) 06/2021
1	Autolysis 08/2020
1	Glioma (Gliomas) 04/2020
1	Skin Neoplasms (Skin Cancer) 01/2020
1	Vesicular Stomatitis 01/2020
1	Persistent Infection 01/2019
1	Osteitis 01/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2018
1	Cryoglobulinemia 01/2018
1	Osteochondroma (Osteocartilaginous Exostosis) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2018
1	Hepatitis D 01/2018
1	Myocardial Infarction 10/2015
1	Breast Neoplasms (Breast Cancer) 01/2015
1	Superinfection 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015
1	Pseudomonas Infections 01/2015
1	Alzheimer Disease (Alzheimer's Disease) 10/2013
1	Chronic Hepatitis B 02/2013
1	Morbid Obesity 01/2013
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Prader-Willi Syndrome (Syndrome, Prader-Willi) 09/2012

Drug/Important Bio-Agent (IBA)

9	Proteins (Proteins, Gene)FDA Link 04/2024 - 02/2003
4	EpitopesIBA 01/2022 - 07/2015
3	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
3	Antiviral Agents (Antivirals)IBA 01/2020 - 02/2013
2	Interferon Type IIBA 10/2023 - 01/2015
2	Peptide Hydrolases (Proteases)FDA Link 11/2022 - 06/2009
2	Biomarkers (Surrogate Marker)IBA 09/2022 - 01/2015
2	VaccinesIBA 01/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 11/2021 - 01/2019
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 07/2015
2	NucleosidesIBA 02/2013 - 06/2010
1	Basic Amino Acids (Basic Amino Acid)IBA 04/2024
1	InterferonsIBA 10/2023
1	Aspartate Ammonia-LyaseIBA 11/2022
1	Threonine (L-Threonine)FDA Link 11/2022
1	Polycomb Repressive Complex 2IBA 01/2022
1	AntibodiesIBA 01/2022
1	Hepatitis B e AntigensIBA 01/2022
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 11/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 06/2021
1	AntigensIBA 06/2021
1	Butyrates (Butyrate)IBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	PolymersIBA 08/2020
1	SaltsIBA 08/2020
1	TrypsinIBA 08/2020
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2020
1	Wnt ProteinsIBA 01/2020
1	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2020
1	alpha E integrinsIBA 01/2020
1	Differentiation AntigensIBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Pancreatic Elastase (Elastase)IBA 03/2019
1	ThermolysinIBA 03/2019
1	Metalloproteases (Metalloproteinases)IBA 03/2019
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2019
1	Virulence Factors (Pathogenicity Factors)IBA 03/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 03/2019
1	TCVSIBA 01/2019
1	purmorphamineIBA 01/2019
1	Broadly Neutralizing AntibodiesIBA 12/2018
1	Immunoglobulin M (IgM)IBA 01/2018
1	HLA-B Antigens (HLA-B)IBA 01/2018
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2018
1	CateninsIBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 08/2017
1	ArginaseIBA 08/2017
1	EnzymesIBA 08/2017
1	LigandsIBA 08/2017
1	fibroblast activation protein alphaIBA 10/2015
1	Interferon-alpha (Interferon Alfa)IBA 01/2015
1	Phosphotransferases (Kinase)IBA 01/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2014
1	NucleotidesIBA 02/2013
1	Cetuximab (Erbitux)FDA Link 01/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	Hyaluronic Acid (Hyaluronan)IBA 01/2013
1	Immunoglobulins (Immunoglobulin)IBA 06/2011

Therapy/Procedure

9	Therapeutics 04/2024 - 01/2012
1	Radiotherapy 11/2021
1	Drug Therapy (Chemotherapy) 04/2020
1	Immunotherapy 01/2020
1	Bariatric Surgery 01/2013